Search

Your search keyword '"Ioannou, Adam"' showing total 8 results
Start Over "Ioannou, Adam" Publication Year Range Last 3 years Publisher wiley
8 results on '"Ioannou, Adam"'

1. Myocardial perfusion in cardiac amyloidosis

Author

Chacko, Liza, primary, Kotecha, Tushar, additional, Ioannou, Adam, additional, Patel, Niket, additional, Martinez‐Naharro, Ana, additional, Razvi, Yousuf, additional, Patel, Rishi, additional, Massa, Paolo, additional, Venneri, Lucia, additional, Brown, James, additional, Porcari, Aldostefano, additional, Knott, Kristopher, additional, Manisty, Charlotte, additional, Knight, Daniel, additional, Lockie, Tim, additional, Rakhit, Roby, additional, Lachmann, Helen, additional, Wechelakar, Ashutosh, additional, Whelan, Carol, additional, Ponticos, Markella, additional, Moon, James, additional, González, Arantxa, additional, Gilbertson, Janet, additional, Riefolo, Mattia, additional, Leone, Ornella, additional, Xue, Hui, additional, Hawkins, Philip, additional, Kellman, Peter, additional, Gillmore, Julian, additional, and Fontana, Marianna, additional

Published
2024
Full Text
View/download PDF

2. Albuminuria in cardiac ATTR amyloidosis: prevalence, progression and prognostic importance

Author

Ioannou, Adam, primary, Rauf, Muhammad U, additional, Patel, Rishi K, additional, Razvi, Yousuf, additional, Porcari, Aldostefano, additional, Martinez‐Naharro, Ana, additional, Venneri, Lucia, additional, Bandera, Francesco, additional, Virsinskaite, Ruta, additional, Kotecha, Tushar, additional, Knight, Dan, additional, Petrie, Aviva, additional, Whelan, Carol, additional, Wechalekar, Ashutosh, additional, Lachmann, Helen, additional, Hawkins, Philip N, additional, Solomon, Scott D, additional, Gillmore, Julian D, additional, and Fontana, Marianna, additional

Published
2023
Full Text
View/download PDF

3. Deep phenotyping of p.(V142I)‐associated variant ATTR amyloid cardiomyopathy: distinct from wild‐type ATTR amyloidosis?

Author

Razvi, Yousuf, primary, Ioannou, Adam, additional, Patel, Rishi K, additional, Chacko, Liza, additional, Karia, Nina, additional, Riefolo, Mattia, additional, Porcari, Aldostefano, additional, Rauf, Muhammad Umaid, additional, Starr, Neasa, additional, Ganesananthan, Sashiananthan, additional, Blakeney, Iona, additional, Kaza, Nandita, additional, Filisetti, Stefano, additional, Bolhuis, Roos Eline, additional, Rowczenio, Dorota, additional, Gilbertson, Janet, additional, Hutt, David, additional, Mahmood, Shameem, additional, Lachmann, Helen J, additional, Wechalekar, Ashutosh D, additional, Kotecha, Tushar, additional, Knight, Daniel S, additional, Coghlan, John G, additional, Petrie, Aviva, additional, Whelan, Carol J, additional, Venneri, Lucia, additional, Martinez‐Naharro, Ana, additional, Hawkins, Phillip, additional, Fontana, Marianna, additional, and Gillmore, Julian D, additional

Published
2023
Full Text
View/download PDF

5. Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy

Author

Porcari, Aldostefano, primary, Razvi, Yousuf, additional, Masi, Ambra, additional, Patel, Rishi, additional, Ioannou, Adam, additional, Rauf, Muhammad U., additional, Hutt, David F., additional, Rowczenio, Dorota, additional, Gilbertson, Janet, additional, Martinez‐Naharro, Ana, additional, Venneri, Lucia, additional, Whelan, Carol, additional, Lachmann, Helen, additional, Wechalekar, Ashutosh, additional, Quarta, Candida Cristina, additional, Merlo, Marco, additional, Sinagra, Gianfranco, additional, Hawkins, Philip N., additional, Fontana, Marianna, additional, and Gillmore, Julian D., additional

Published
2023
Full Text
View/download PDF

6. Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis

Author

Patel, Rishi K., primary, Ioannou, Adam, additional, Razvi, Yousuf, additional, Chacko, Liza, additional, Venneri, Lucia, additional, Bandera, Francesco, additional, Knight, Daniel, additional, Kotecha, Tushar, additional, Martinez‐Naharro, Ana, additional, Masi, Ambra, additional, Porcari, Aldostefano, additional, Brown, James, additional, Patel, Kiara, additional, Manisty, Charlotte, additional, Moon, James, additional, Rowczenio, Dorota, additional, Gilbertson, Janet A., additional, Sinagra, Gianfranco, additional, Lachmann, Helen, additional, Wechalekar, Ashutosh, additional, Petrie, Aviva, additional, Whelan, Carol, additional, Hawkins, Philip N., additional, Gillmore, Julian D., additional, and Fontana, Marianna, additional

Published
2022
Full Text
View/download PDF

7. Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

Author

Chacko, Liza, primary, Karia, Nina, additional, Venneri, Lucia, additional, Bandera, Francesco, additional, Passo, Beatrice Dal, additional, Buonamici, Lodovico, additional, Lazari, Jonathan, additional, Ioannou, Adam, additional, Porcari, Aldostefano, additional, Patel, Rishi, additional, Razvi, Yousuf, additional, Brown, James, additional, Knight, Daniel, additional, Martinez‐Naharro, Ana, additional, Whelan, Carol, additional, Quarta, Candida C., additional, Manisty, Charlotte, additional, Moon, James, additional, Rowczenio, Dorota, additional, Gilbertson, Janet A., additional, Lachmann, Helen, additional, Wechelakar, Ashutosh, additional, Petrie, Aviva, additional, Moody, William E., additional, Steeds, Richard P., additional, Potena, Luciano, additional, Riefolo, Mattia, additional, Leone, Ornella, additional, Rapezzi, Claudio, additional, Hawkins, Philip N., additional, Gillmore, Julian D., additional, and Fontana, Marianna, additional

Published
2022
Full Text
View/download PDF

8. Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis

Author

Rishi K. Patel, Adam Ioannou, Yousuf Razvi, Liza Chacko, Lucia Venneri, Francesco Bandera, Daniel Knight, Tushar Kotecha, Ana Martinez‐Naharro, Ambra Masi, Aldostefano Porcari, James Brown, Kiara Patel, Charlotte Manisty, James Moon, Dorota Rowczenio, Janet A. Gilbertson, Gianfranco Sinagra, Helen Lachmann, Ashutosh Wechalekar, Aviva Petrie, Carol Whelan, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana, Patel, Rishi K., Ioannou, Adam, Razvi, Yousuf, Chacko, Liza, Venneri, Lucia, Bandera, Francesco, Knight, Daniel, Kotecha, Tushar, Martinez-Naharro, Ana, Masi, Ambra, Porcari, Aldostefano, Brown, Jame, Patel, Kiara, Manisty, Charlotte, Moon, Jame, Rowczenio, Dorota, Gilbertson, Janet A., Sinagra, Gianfranco, Lachmann, Helen, Wechalekar, Ashutosh, Petrie, Aviva, Whelan, Carol, Hawkins, Philip N., Gillmore, Julian D., and Fontana, Marianna

Subjects
Male, Heart Failure, Amyloid Neuropathies, Familial, Sex Characteristics, diagnosis, Amyloidosis, Prognosis, echocardiography, sex, prognosis, diagnosi, Disease Progression, Amyloidosi, Humans, Prealbumin, Female, Cardiomyopathies, Cardiology and Cardiovascular Medicine
Abstract

Aims: transthyretin amyloid cardiomyopathy (ATTR-CM) is predominantly diagnosed in men. The few available studies suggest affected women have a more favourable cardiac phenotype. We aimed to characterize sex differences among consecutive patients with non-hereditary and two prevalent forms of hereditary (h)ATTR-CM diagnosed over a 20-year period. Methods and results: analysis of deep phenotyping at presentation, changes on serial echocardiography and overall prognosis were evaluated. In total, 1732 consecutive patients were studied, comprising: 1095 with wild-type (wt)ATTR-CM; 206 with T60A-hATTR-CM; and 431 with V122I-hATTR-CM. Female prevalence was greater in T60A-hATTR-CM (29.6%) and V122I-hATTR-CM (27.8%) compared to wtATTR-CM (6%). At presentation, females were 3.3 years older than males (wtATTR-CM: 81.9 vs. 77.8 years; T60A-hATTR-CM: 68.7 vs. 65.1 years; V122I-hATTR-CM: 77.1 vs. 74.9 years). Body size significantly influenced measures of disease severity; when indexed, overall structural and functional phenotype was similar between sexes, the few significant differences suggested a mildly worse phenotype in females. No significant differences were observed in both disease progression on serial echocardiography and mortality across the overall population (p = 0.459) and when divided by genotype (wtATTR-CM: p = 0.730; T60A-hATTR-CM: p = 0.161; V122I-hATTR-CM: p = 0.056). Conclusion: this study of a well-characterized large cohort of ATTR-CM patients did not demonstrate overall differences between sexes in either clinical phenotype, when indexed, or with respect to disease progression and prognosis. Non-indexed wall thickness measurements may have contributed to both under-representation and delays in diagnosis for affected females and highlights the potential role of utilizing indexed echocardiographic parameters for a more accurate assessment of patients at diagnosis and for disease prognostication.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results